Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02286167 · ClinicalTrials.gov registry record · NA
Glioma Modified Atkins-based Diet in Patients With Glioblastoma
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02286167 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 25 participants.
The verdict
NCT02286167, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The primary goal of this study is to assess the feasibility and biologic activity of a modified Atkins-based diet combined with short-term intermittent fasting, a GLioma Atkins-based Diet (GLAD), in patients with central nervous system GBM.
Interventions
- OTHER Diet modification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2014-11 |
| Est. Completion | 2019-07-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02286167
The ClinicalTrials.gov registry entry for NCT02286167 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diet modification is the first listed.
NCT02286167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02286167 about?
NCT02286167 is a clinical study titled "Glioma Modified Atkins-based Diet in Patients With Glioblastoma". The primary goal of this study is to assess the feasibility and biologic activity of a modified Atkins-based diet combined with short-term intermittent fasting, a GLioma Atkins-based Diet (GLAD), in patients with central nervous system GBM.
What is the current status of trial NCT02286167?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2014-11. Estimated completion is 2019-07-12.
What interventions are being tested in trial NCT02286167?
The interventions under investigation include: Diet modification (OTHER).
Who is sponsoring clinical trial NCT02286167?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.